Frankfurt
17.03.25 | 08:52
3,000 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.03. | OPTHEA LIMITED: Appendix 4D and Half Year Report for period 31 Dec 2025 | 1 | ASX | ||
| 29.01. | OPTHEA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | 1 | ASX | ||
| 22.01. | OPTHEA LIMITED: Long Term Suspended Entities | 6 | ASX | ||
| 15.01. | OPTHEA LIMITED: Notification of cessation of securities - OPT | 2 | ASX | ||
| 22.12.25 | OPTHEA LIMITED: Change of Director's Interest Notice - KC & LG | - | ASX | ||
| OPTHEA LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 19.12.25 | OPTHEA LIMITED: Notification regarding unquoted securities - OPT | 1 | ASX | ||
| 17.12.25 | Health Check: No longer sheepish, Opthea flags fresh start | 3 | Stockhead | ||
| 17.12.25 | OPTHEA LIMITED: Investor Update Presentation | 1 | ASX | ||
| 11.12.25 | OPTHEA LIMITED: Notice of Market Update | 16 | ASX | ||
| 07.12.25 | OPTHEA LIMITED: Change in substantial holding | - | ASX | ||
| 20.11.25 | OPTHEA LIMITED: Voluntary delisting from Nasdaq takes effect | 1 | ASX | ||
| 20.11.25 | Opthea Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12.11.25 | Opthea Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.11.25 | OPTHEA LIMITED: Results of AGM | 1 | ASX | ||
| 10.11.25 | Opthea Ltd - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | - | SEC Filings | ||
| 30.10.25 | OPTHEA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 30.10.25 | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.10.25 | OPTHEA LIMITED: Opthea announces intention to delist from Nasdaq | - | ASX | ||
| 27.10.25 | Opthea Appoints Hamish George As CFO | - | RTTNews | ||
| 26.10.25 | OPTHEA LIMITED: Appointment of Company Secretary and CFO | 1 | ASX |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALATIN TECHNOLOGIES | 18,650 | -11,19 % | Morning Market Movers: Super Micro Computer, Bimergen Energy, Palatin Technologies, Intellicheck See Big Swings | HONG KONG (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 0,770 | -0,65 % | COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) ("COSCIENS" or the "Company"), a life science company focused on the development of natural... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 53,64 | -1,03 % | Halozyme Therapeutics, Inc.: U.S. FDA Approves TECVAYLI in Combination with DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma | FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care... ► Artikel lesen | |
| ABCELLERA BIOLOGICS | 2,823 | -1,53 % | AbCellera auf dem KeyBanc Forum: Strategische Fortschritte im Biotech-Sektor | ||
| GLOW LIFETECH | 0,028 | +1,82 % | Glow Lifetech Corp.: Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired | Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce a significant reduction in its outstanding... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 234,00 | -0,89 % | Bio-Rad Laboratories Swings To Q4 Profit | WASHINGTON (dpa-AFX) - Bio-Rad Laboratories, Inc. (BIO), a life science and diagnostic company, on Thursday, reported strong financial performance for the fourth quarter and full year 2025.... ► Artikel lesen | |
| AVID BIOSERVICES | - | - | Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California | COSTA MESA, Calif., Feb. 24, 2026 /PRNewswire/ -- Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state... ► Artikel lesen | |
| BIOLINERX | 1,950 | +6,79 % | BioLineRx Ltd.: BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) | GLIX1, a TET2 activator, is a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers
GLIX1 has demonstrated potent... ► Artikel lesen | |
| MINERVA NEUROSCIENCES | 5,150 | 0,00 % | Minerva Neurosciences, Inc: Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026 | Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine
The Company continues to advance the program, with the confirmatory Phase 3 trial now enrolling and topline... ► Artikel lesen | |
| WHITEHAWK THERAPEUTICS | 3,160 | +10,49 % | Whitehawk Therapeutics, Inc.: Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer | Dr. Dugan brings extensive clinical development leadership to Whitehawk as ADC programs near the clinic
MORRISTOWN, N.J., Dec. 1, 2025 /PRNewswire/ -- Whitehawk... ► Artikel lesen | |
| PARATEK PHARMACEUTICALS | - | - | Paratek Pharmaceuticals: $1.3 Billion Financing Supports Radius Health Combination To Build Specialty Pharma Platform | ||
| OVID THERAPEUTICS | 1,850 | +0,54 % | Ovid Therapeutics Inc.: Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer | NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need,... ► Artikel lesen | |
| APPLIED THERAPEUTICS | 0,077 | 0,00 % | Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics | Cycle Group Holdings Limited ("Cycle") is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: APLT; "Applied"), a clinical-stage biopharmaceutical... ► Artikel lesen | |
| GEOVAX LABS | 1,340 | -4,29 % | EQS-News: GeoVax, Inc.: GeoVax Provides Update on GEO-MVA Program | EQS-News: GeoVax, Inc.
/ Key word(s): Financial
GeoVax Provides Update on GEO-MVA Program 25.03.2026 / 14:03 CET/CEST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| PRECISION BIOSCIENCES | 4,760 | +0,85 % | Precision BioSciences: Sind das jetzt Super-Schnäppchen? | Die Aktie von Precision BioSciences ist eines der wenigen Biotech-Papiere, die in diesem Jahr keinen Höhenflug erlebten. Im Gegenteil: Die Aktie hat ohne schlechte Unternehmensnews in den letzten Monaten... ► Artikel lesen |
Das Unternehmen OPTHEA LIMITED ADR kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 3,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTHEA LIMITED ADR finden Sie auf Wallstreet Online.